News
Just as no serious business today can operate without an internet strategy, no life sciences organization will remain ...
4d
TipRanks on MSNPMV Pharmaceuticals Reports Promising Phase 2 Trial Results
PMV Pharmaceuticals ( ($PMVP) ) has provided an update. On September 10, 2025, PMV Pharmaceuticals announced interim data from their Phase 2 ...
The detailed results from the HARMONi trial—the first global phase 3 data set for the world’s first PD-1xVEGF bispecific, ...
4d
GlobalData on MSNAvidity touts disease reversal potential of DMD therapy
Avidity Biosciences’ Duchenne muscular dystrophy (DMD) therapy, del-zota, demonstrated reversal of disease progression in a ...
Hi. Welcome, everyone, to this session of the Morgan Stanley Global Healthcare Conference. We're thrilled to have the Incyte team with us represented by Bill and Dr. Steven Stein. I'm Judah Frommer, ...
Revolution Medicines, Inc. shares surged on strong Phase 1 data for daraxonrasib in metastatic pancreatic cancer. Click here ...
Perhaps such a transition will be increasingly adaptive. Faced with growing ecological and social crises, the current configuration of human society—atomized, slow to coordinate, prone to ...
The rising prevalence of cancer worldwide, increasing adoption of minimally invasive diagnostic tests, and advances in ...
They look like ordinary horses, with their honey brown coats and white patches. But these 10-month-old foals in Argentina are ...
3don MSN
Russia claims cancer vaccine reduces tumors by 80 percent... announces it is safe and 'ready to use'
Officials in Russia have announced a potential breakthrough against colorectal cancer, though the details of the researchers' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results